Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trond Hellem Bø

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|February 24, 2004
LSimpute: accurate estimation of missing values in microarray data with least squares methodsTrond Hellem Bø, Bjarte Dysvik, Inge Jonassen
BMC Bioinformatics|December 4, 2003
Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray dataJunbai Wang, Trond Hellem Bø, Inge Jonassen, et al.
International Journal of Oncology|April 6, 2006
cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiationAnne Margrete Øyan, Trond Hellem Bø, Inge Jonassen, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in acute myeloid leukemiaAnne Margrete Oyan, Trond Hellem Bø, Inge Jonassen, et al.
Cytometry. Part B, Clinical Cytometry|January 26, 2005
CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profilesAnne Margrete Oyan, Trond Hellem Bø, Inge Jonassen, et al.
BMC Cancer|March 7, 2009
Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemiaAnne Margrete Øyan, Nina Anensen, Trond Hellem Bø, et al.
The American Journal of Pathology|February 2, 2011
Gene expression patterns related to vascular invasion and aggressive features in endometrial cancerMonica Mannelqvist, Ingunn M Stefansson, Geir Bredholt, et al.
Oncotarget|October 21, 2015
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responsesGeir Bredholt, Monica Mannelqvist, Ingunn M Stefansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancerOle Johan Halvorsen, Kari Rostad, Anne Margrete Øyan, et al.
International Journal of Oncology|December 5, 2006
ERG upregulation and related ETS transcription factors in prostate cancerKari Rostad, Monica Mannelqvist, Ole Johan Halvorsen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|February 24, 2004
LSimpute: accurate estimation of missing values in microarray data with least squares methodsTrond Hellem Bø, Bjarte Dysvik, Inge Jonassen
BMC Bioinformatics|December 4, 2003
Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray dataJunbai Wang, Trond Hellem Bø, Inge Jonassen, et al.
International Journal of Oncology|April 6, 2006
cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiationAnne Margrete Øyan, Trond Hellem Bø, Inge Jonassen, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in acute myeloid leukemiaAnne Margrete Oyan, Trond Hellem Bø, Inge Jonassen, et al.
Cytometry. Part B, Clinical Cytometry|January 26, 2005
CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profilesAnne Margrete Oyan, Trond Hellem Bø, Inge Jonassen, et al.
BMC Cancer|March 7, 2009
Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemiaAnne Margrete Øyan, Nina Anensen, Trond Hellem Bø, et al.
The American Journal of Pathology|February 2, 2011
Gene expression patterns related to vascular invasion and aggressive features in endometrial cancerMonica Mannelqvist, Ingunn M Stefansson, Geir Bredholt, et al.
Oncotarget|October 21, 2015
Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responsesGeir Bredholt, Monica Mannelqvist, Ingunn M Stefansson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancerOle Johan Halvorsen, Kari Rostad, Anne Margrete Øyan, et al.
International Journal of Oncology|December 5, 2006
ERG upregulation and related ETS transcription factors in prostate cancerKari Rostad, Monica Mannelqvist, Ole Johan Halvorsen, et al.
Pageof 2